The DOI matches its Crossref record.
‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometry
Abstract
Summary: ‘Classical organic acidurias’ comprise isovaleric aciduria, propionic aciduria and methylmalonic aciduria. Available data from the literature suggest that the use of ‘new’ therapeutic strategies has improved survival but has not modified neurodevelopment. Progressive neurocognitive deterioration is almost invariably present in propionic and methylmalonic acidurias, while large‐scale studies on the long‐term outcome of patients with isovaleric aciduria are still lacking. In order to answer to some of the questions suggested by Wilson and Jungner in 1968 about the criteria of disease screening, we compared the natural history of patients with ‘classical’ organic acidurias diagnosed on clinical bases to those diagnosed through neonatal mass screening using tandem mass spectrometry. Decreased early mortality, less severe symptoms at diagnosis, and more favourable short‐term neurodevelopmental outcome were recorded in patients identified through expanded newborn screening. The short duration of follow‐up so far does not allow us to draw final conclusions about the effects of newborn screening on long‐term outcome. The evaluation of the effect of neonatal screening on the detection rate of these three diseases showed that the incidence of isovaleric aciduria was significantly higher in the screening population than in clinically detected cases, with no changes for propionic and methylmalonic acidurias. Further multicentre longitudinal studies are needed to assess the usefulness of expanded newborn screening for ‘classical’ organic acidurias and to better understand the clinical spectrum of these diseases. This paper describes the long‐term outcome and the impact of expanded newborn screening on the so‐called ‘classical’ organic acidurias (propionic aciduria, methylmalonic aciduria and isovaleric aciduria).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
Baumgartner, M. R., Hörster, F., Dionisi-Vici, C., Haliloglu, G., Karall, D., Chapman, K. A., Huemer, M., Hochuli, M., Assoun, M., Ballhausen, D., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0130-8 · Cited by 705
Self-citationForny, P., Hörster, F., Ballhausen, D., Chakrapani, A., Chapman, K. A., Dionisi‐Vici, C., Dixon, M., Grünert, S. C., Grunewald, S., Haliloglu, G., et al. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12370 · Cited by 287
Self-citationSystemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
An, D., Schneller, J. L., Frassetto, A., Liang, S., Zhu, X., Park, J.-S., Theisen, M., Hong, S.-J., Zhou, J., Rajendran, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.081 · Cited by 263
Metadata
- Authors
- Dionisi‐Vici, C., Deodato, F., Röschinger, W., Rhead, W., & Wilcken, B.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2006-04
- Volume
- 29
- Issue
- 2-3
- Pages
- 383-389
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1996115007
- Cited by
- 243
- References
- 0
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometry. https://app.cochat.ai/papers/10.1007/s10545-006-0278-z
- The paper
- Dionisi‐Vici, C., Deodato, F., Röschinger, W., Rhead, W., & Wilcken, B. (2006). ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometry. Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-006-0278-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.